Massimo Guidoboni

Massimo Guidoboni

Università degli Studi di Ferrara - Ferrara / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5290154
University of Ferrara
person_outline Massimo Guidoboni's MOST POPULAR ARTICLES
1-) Overall survival with combined nivolumab and ipilimumab in advanced melanoma JD Wolchok, V Chiarion-Sileni, R Gonzalez, P Rutkowski, JJ Grob, ... New England Journal of Medicine 377 (14), 1345-1356, 2017 35372017
2-) Five-year survival with combined nivolumab and ipilimumab in advanced melanoma J Larkin, V Chiarion-Sileni, R Gonzalez, JJ Grob, P Rutkowski, CD Lao, ... New England journal of medicine 381 (16), 1535-1546, 2019 30232019
3-) Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanomaJD Wolchok, V Chiarion-Sileni, R Gonzalez, JJ Grob, P Rutkowski, ...Journal of Clinical Oncology 40 (2), 127-137, 20227122022
4-) Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal LymphomasAJM Ferreri, M Guidoboni, M Ponzoni, C De Conciliis, S Dell’Oro, ...Journal of the National Cancer Institute 96 (8), 586-594, 20046862004
5-) High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instabilityR Dolcetti, A Viel, C Doglioni, A Russo, M Guidoboni, E Capozzi, ...The American journal of pathology 154 (6), 1805-1813, 19995931999